Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

White House focusing on vaccine access for vulnerable

Por: The Hill Health January 31, 2023

thumbnail

The White House is making it a priority to ensure vulnerable populations have access to needed vaccines, a top administration health official said. Chiquita Brooks-LaSure, administrator of the Centers for Medicare and Medicaid Services, said many of the most vulnerable in the country are seniors and disabled people on Medicare. In many cases, they are either unaware they need a particular vaccine or they can’t afford it because of Medicare... + full article



Similar News

FDA proposes switching to annual coronavirus vaccine, mimicking flu model

Portland Press Herald USA World January 24, 2023

thumbnailThe Food and Drug Administration is proposing a crucial change in the way the coronavirus vaccine is handled: Switching to a once-a-year shot that targets the strain expected to pose the greatest threat during the following winter – a system akin to what is used for the... + más

Flu cases and hospitalizations surging to our south, and headed north | Portland Press Herald

One step closer to a universal flu vaccine? | The Boston Globe


San Diego Unified's COVID-19 vaccine mandate struck down in court — again

Los Angeles Times USA Nation November 24, 2022

thumbnailA California appeals court ruled against the San Diego Unified School District's COVID-19 student vaccine mandate, which has been on pause for the last half-year. The 4th District Court of Appeal agreed Tuesday with a lower court's ruling from December that school... + más

For subscribers: San Diego Unified race becomes partisan brawl | Los Angeles Times

Judge orders NYPD union members fired over vax mandate reinstated | New York Post


Pfizer announces promising developments for 1st maternal RSV vaccine

ABC News USA Life November 01, 2022

thumbnailAfter decades of researching respiratory syncytial virus, an , scientists this week announced a major development in plans for a possible vaccine that could be available as soon as next year.Among very young children, particularly those [younger] than 6 months of age, we have a... + más

After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year | CNN

Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS


FDA authorizes Novavax Covid-19 vaccine for use as a first booster shot

CNN USA Health October 19, 2022

thumbnailCNN  —  The US Food and Drug Administration on Wednesday among adults 18 and older, at least six months after completing a primary Covid-19 vaccine series. The company announced that it has received emergency use authorization to provide a first booster dose of its vaccine... + más

FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or Moderna | CNBC

US clears Novavax COVID booster dose | ABC News


Cancer vaccine may be ready by 2030, say founders of COVID vaccine-makers BioNTech

ABC7 USA Health October 18, 2022

thumbnailin an interview over the weekend. Her husband, professor Ugur Sahin, with whom she cofounded the German pharmaceutical company BioNTech, said he thought cancer vaccines could be widely available before 2030.The husband-and-wife duo founded BioNTech in 2008 originally to develop... + más

Cancer vaccine may be ready by 2030, say founders of COVID vaccine makers BioNTech | ABC News

In Boston visit, BioNTech’s leaders say the pandemic isn’t close to being over | The Boston Globe


Cancer vaccine may be ready by 2030, say founders of COVID vaccine makers BioNTech

ABC News USA World October 18, 2022

thumbnailLONDON -- The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine.We feel that a cure for cancer or to changing cancer patients' lives is in our grasp, professor Ozlem Tureci told in an interview... + más

Cancer vaccine may be ready by 2030, say founders of COVID vaccine-makers BioNTech | ABC7

In Boston visit, BioNTech’s leaders say the pandemic isn’t close to being over | The Boston Globe


Moderna to seek emergency authorization for COVID-19 vaccine use for kids under 6

New York Daily News USA Health October 10, 2022

thumbnailKids, prep those arms. Moderna announced Wednesday that it’s ready to ask the Food and Drug Administration for emergency authorization to begin administering the COVID-19 vaccine to children under 6 years old after testing a lower-dosage shot on about 6,700 participants. Two... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge



About iurex | Privacy Policy | Disclaimer |